393 related articles for article (PubMed ID: 11772119)
1. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
Waintraub L; Septien L; Azoulay P
CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
[TBL] [Abstract][Full Text] [Related]
2. [Major depressive episodes in patients over 70 years of age. Evaluation of the efficiency and acceptability of tianeptine and mianserin].
Brion S; Audrain S; de Bodinat C
Presse Med; 1996 Mar; 25(9):461-8. PubMed ID: 8685201
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
Cassano GB; Jori MC;
Int Clin Psychopharmacol; 2002 Jan; 17(1):27-32. PubMed ID: 11800503
[TBL] [Abstract][Full Text] [Related]
5. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.
Szegedi A; Kohnen R; Dienel A; Kieser M
BMJ; 2005 Mar; 330(7490):503. PubMed ID: 15708844
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine.
Lôo H; Saiz-Ruiz J; Costa e Silva JACE ; Ansseau M; Herrington R; Vaz-Serra A; Dilling H; de Risio S
J Affect Disord; 1999 Dec; 56(2-3):109-18. PubMed ID: 10701468
[TBL] [Abstract][Full Text] [Related]
7. Clinical safety and efficacy of tianeptine in 1,858 depressed patients treated in general practice.
Guelfi JD; Dulcire C; Le Moine P; Tafani A
Neuropsychobiology; 1992; 25(3):140-8. PubMed ID: 1407480
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
[TBL] [Abstract][Full Text] [Related]
9. Tianeptine and amitriptyline. Controlled double-blind trial in depressed alcoholic patients.
Lôo H; Malka R; Defrance R; Barrucand D; Benard JY; Niox-Rivière H; Raab A; Sarda A; Vachonfrance G; Kamoun A
Neuropsychobiology; 1988; 19(2):79-85. PubMed ID: 3067116
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study.
Emsley R; Ahokas A; Suarez A; Marinescu D; Dóci I; Lehtmets A; Milanova V; Lee MS; Didi R; Araszkiewicz A; Sulaiman AH; Blanchot FP; Crutel VS; Antoine C; Penelaud PF
J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 29995359
[TBL] [Abstract][Full Text] [Related]
11. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
[TBL] [Abstract][Full Text] [Related]
12. [Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment].
Daléry J; Dagens-Lafant V; De Bodinat C
Encephale; 1997; 23(1):56-64. PubMed ID: 9172969
[TBL] [Abstract][Full Text] [Related]
13. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
Schruers K; Griez E
J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
[TBL] [Abstract][Full Text] [Related]
14. Clinical and neurobiological effects of tianeptine and paroxetine in major depression.
Nickel T; Sonntag A; Schill J; Zobel AW; Ackl N; Brunnauer A; Murck H; Ising M; Yassouridis A; Steiger A; Zihl J; Holsboer F
J Clin Psychopharmacol; 2003 Apr; 23(2):155-68. PubMed ID: 12640217
[TBL] [Abstract][Full Text] [Related]
15. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.
Le Noury J; Nardo JM; Healy D; Jureidini J; Raven M; Tufanaru C; Abi-Jaoude E
BMJ; 2015 Sep; 351():h4320. PubMed ID: 26376805
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine compared with paroxetine in major depression.
Benkert O; Szegedi A; Kohnen R
J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
[TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled study of tianeptine in major depressive episodes.
Costa e Silva JA; Ruschel SI; Caetano D; Rocha FL; da Silva Lippi JR; Arruda S; Ozun M
Neuropsychobiology; 1997; 35(1):24-9. PubMed ID: 9018020
[TBL] [Abstract][Full Text] [Related]
18. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
[TBL] [Abstract][Full Text] [Related]
19. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
[TBL] [Abstract][Full Text] [Related]
20. [Tolerability of tianeptine in 170 patients with depression treated during one year].
Lôo H; Ganry H; Marey C; Briole G; Castelnau D; Charbonnier JF; Dachary JM; Danion JM; Darcourt G; Capdeville C
Encephale; 1990; 16(6):445-52. PubMed ID: 2101783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
